133 related articles for article (PubMed ID: 17385588)
1. Oral transmucosal fentanyl citrate versus placebo for painful dressing changes: a crossover trial.
MacIntyre PA; Margetts L; Larsen D; Barker L
J Wound Care; 2007 Mar; 16(3):118-21. PubMed ID: 17385588
[TBL] [Abstract][Full Text] [Related]
2. A comparison of intranasal fentanyl spray with oral transmucosal fentanyl citrate for the treatment of breakthrough cancer pain: an open-label, randomised, crossover trial.
Mercadante S; Radbruch L; Davies A; Poulain P; Sitte T; Perkins P; Colberg T; Camba MA
Curr Med Res Opin; 2009 Nov; 25(11):2805-15. PubMed ID: 19792837
[TBL] [Abstract][Full Text] [Related]
3. Tolerability and effects of two formulations of oral transmucosal fentanyl citrate (OTFC; ACTIQ) in patients with radiation-induced oral mucositis.
Shaiova L; Lapin J; Manco LS; Shasha D; Hu K; Harrison L; Portenoy RK
Support Care Cancer; 2004 Apr; 12(4):268-73. PubMed ID: 14750002
[TBL] [Abstract][Full Text] [Related]
4. Oral transmucosal fentanyl citrate (OTFC) for the treatment of breakthrough pain in cancer patients: a controlled dose titration study.
Portenoy RK; Payne R; Coluzzi P; Raschko JW; Lyss A; Busch MA; Frigerio V; Ingham J; Loseth DB; Nordbrock E; Rhiner M
Pain; 1999 Feb; 79(2-3):303-12. PubMed ID: 10068176
[TBL] [Abstract][Full Text] [Related]
5. Breakthrough cancer pain: a randomized trial comparing oral transmucosal fentanyl citrate (OTFC) and morphine sulfate immediate release (MSIR).
Coluzzi PH; Schwartzberg L; Conroy JD; Charapata S; Gay M; Busch MA; Chavez J; Ashley J; Lebo D; McCracken M; Portenoy RK
Pain; 2001 Mar; 91(1-2):123-30. PubMed ID: 11240084
[TBL] [Abstract][Full Text] [Related]
6. Oral transmucosal fentanyl citrate: randomized, double-blinded, placebo-controlled trial for treatment of breakthrough pain in cancer patients.
Farrar JT; Cleary J; Rauck R; Busch M; Nordbrock E
J Natl Cancer Inst; 1998 Apr; 90(8):611-6. PubMed ID: 9554444
[TBL] [Abstract][Full Text] [Related]
7. Oral transmucosal fentanyl citrate for the treatment of migraine headache pain in outpatients: a case series.
Landy SH
Headache; 2004 Sep; 44(8):762-6. PubMed ID: 15330821
[TBL] [Abstract][Full Text] [Related]
8. A randomized clinical trial of oral transmucosal fentanyl citrate versus intravenous morphine sulfate for initial control of pain in children with extremity injuries.
Mahar PJ; Rana JA; Kennedy CS; Christopher NC
Pediatr Emerg Care; 2007 Aug; 23(8):544-8. PubMed ID: 17726413
[TBL] [Abstract][Full Text] [Related]
9. The relative potency of oral transmucosal fentanyl citrate compared with intravenous morphine in the treatment of moderate to severe postoperative pain.
Lichtor JL; Sevarino FB; Joshi GP; Busch MA; Nordbrock E; Ginsberg B
Anesth Analg; 1999 Sep; 89(3):732-8. PubMed ID: 10475315
[TBL] [Abstract][Full Text] [Related]
10. Relative bioavailability of the fentanyl effervescent buccal tablet (FEBT) 1,080 pg versus oral transmucosal fentanyl citrate 1,600 pg and dose proportionality of FEBT 270 to 1,300 microg: a single-dose, randomized, open-label, three-period study in healthy adult volunteers.
Darwish M; Tempero K; Kirby M; Thompson J
Clin Ther; 2006 May; 28(5):715-24. PubMed ID: 16861093
[TBL] [Abstract][Full Text] [Related]
11. Oral transmucosal fentanyl citrate: a novel analgesic agent for use in retinal photocoagulation.
Hillier RJ; Aboud A; Thind G; Clark DI
Retina; 2009; 29(10):1506-12. PubMed ID: 19696704
[TBL] [Abstract][Full Text] [Related]
12. A comparison of oral transmucosal fentanyl citrate and oral oxycodone for pediatric outpatient wound care.
Sharar SR; Carrougher GJ; Selzer K; O'Donnell F; Vavilala MS; Lee LA
J Burn Care Rehabil; 2002; 23(1):27-31. PubMed ID: 11803309
[TBL] [Abstract][Full Text] [Related]
13. Intranasal fentanyl is an equivalent analgesic to oral morphine in paediatric burns patients for dressing changes: a randomised double blind crossover study.
Borland ML; Bergesio R; Pascoe EM; Turner S; Woodger S
Burns; 2005 Nov; 31(7):831-7. PubMed ID: 16005154
[TBL] [Abstract][Full Text] [Related]
14. Oral transmucosal fentanyl citrate for premedication in adults.
Macaluso AD; Connelly AM; Hayes WB; Holub MC; Ramsay MA; Suit CT; Hein HA; Swygert TH
Anesth Analg; 1996 Jan; 82(1):158-61. PubMed ID: 8712394
[TBL] [Abstract][Full Text] [Related]
15. [Oral transmucosal fentanyl citrate (OTFC) in the treatment of breakthrough pain].
Borgbjerg FM; Rosenberg J
Ugeskr Laeger; 2000 Sep; 162(39):5237-40. PubMed ID: 11043058
[TBL] [Abstract][Full Text] [Related]
16. Fentanyl buccal tablet for the relief of breakthrough pain in opioid-tolerant adult patients with chronic neuropathic pain: a multicenter, randomized, double-blind, placebo-controlled study.
Simpson DM; Messina J; Xie F; Hale M
Clin Ther; 2007 Apr; 29(4):588-601. PubMed ID: 17617282
[TBL] [Abstract][Full Text] [Related]
17. Long-term safety of oral transmucosal fentanyl citrate for breakthrough cancer pain.
Payne R; Coluzzi P; Hart L; Simmonds M; Lyss A; Rauck R; Berris R; Busch MA; Nordbrook E; Loseth DB; Portenoy RK
J Pain Symptom Manage; 2001 Jul; 22(1):575-83. PubMed ID: 11516599
[TBL] [Abstract][Full Text] [Related]
18. Factors in the choice of oral transmucosal fentanyl citrate dose for adult burns dressings.
Shah H; Smythe J; Hanafiah Z; Williams GJ; Holdcroft A
Burns; 2009 Sep; 35(6):798-801. PubMed ID: 19167829
[TBL] [Abstract][Full Text] [Related]
19. Dose-titration, multicenter study of oral transmucosal fentanyl citrate for the treatment of breakthrough pain in cancer patients using transdermal fentanyl for persistent pain.
Christie JM; Simmonds M; Patt R; Coluzzi P; Busch MA; Nordbrock E; Portenoy RK
J Clin Oncol; 1998 Oct; 16(10):3238-45. PubMed ID: 9779697
[TBL] [Abstract][Full Text] [Related]
20. Absolute and relative bioavailability of fentanyl buccal tablet and oral transmucosal fentanyl citrate.
Darwish M; Kirby M; Robertson P; Tracewell W; Jiang JG
J Clin Pharmacol; 2007 Mar; 47(3):343-50. PubMed ID: 17322146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
